Embecta (FRA:JX7) Total Tax Payable : €26 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Embecta Total Tax Payable?

Embecta's Total Tax Payable for the quarter that ended in Mar. 2024 was €26 Mil.

Embecta's quarterly Total Tax Payable declined from Sep. 2023 (€31 Mil) to Dec. 2023 (€31 Mil) and declined from Dec. 2023 (€31 Mil) to Mar. 2024 (€26 Mil).

Embecta's annual Total Tax Payable increased from Sep. 2021 (€0 Mil) to Sep. 2022 (€27 Mil) and increased from Sep. 2022 (€27 Mil) to Sep. 2023 (€31 Mil).

Embecta Total Tax Payable Historical Data

The historical data trend for Embecta's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embecta Total Tax Payable Chart

Embecta Annual Data

Trend

Sep19

Sep20

Sep21

Sep22

Sep23

Total Tax Payable

27.47

31.48

Embecta Quarterly Data
	Sep19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Tax Payable	Get a 7-Day Free Trial											33.16	32.67	31.48	31.27	25.67

Embecta Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Embecta Total Tax Payable Related Terms

Thank you for viewing the detailed overview of Embecta's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Embecta (FRA:JX7) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embecta Corp (FRA:JX7) » Definitions » Total Tax Payable

Comparable Companies

Traded in Other Exchanges

EMBC:USA JX7:Germany

Address

300 Kimball Drive, Suite 300, Parsippany, NJ, USA, 07054

Website

https://www.embecta.com

Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.

Embecta (FRA:JX7) Headlines

No Headlines